BML-111 Attenuates Renal Ischemia/Reperfusion Injury Via Peroxisome Proliferator-Activated Receptor-α-Regulated Heme Oxygenase-1

Inflammation

Volumn 39, Issue 2, 2016, Pages 611-624

  Wu, Sheng Hua ^a   Chen, Xiao Qing ^a   Lü, Jing ^a   Wang, Ming Jie ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

BML 111; heme oxygenase 1; ischemia reperfusion injury; kidney; lipoxins; p38 mitogen activated protein kinase; peroxisome proliferator activated receptor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5,6,7 TRIHYDROXYHEPTANOIC ACID METHYL ESTER; CREATININE; CYTOSOL AMINOPEPTIDASE; GW 6471; HEME OXYGENASE 1; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LUCIFERASE; MALONALDEHYDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; N ACETYL BETA GLUCOSAMINIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; PIRINIXIC ACID; PROTOPORPHYRIN ZINC; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG; URINARY TRACT AGENT; 5(S),6(R)-7-TRIHYDROXYHEPTANOIC ACID, METHYL ESTER; BETA GLUCURONIDASE; HEPTANOIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE; LIPOXIN RECEPTOR; N-ACETYL-BETA-GLUCURONIDASE; OXAZOLE DERIVATIVE; PEROXIDASE; PROTOPORPHYRIN; PYRIDINE DERIVATIVE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG PROTEIN BINDING; ENZYME ACTIVATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INJURY SEVERITY; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; LIPID PEROXIDATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RENAL PROTECTION; REPERFUSION INJURY; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BLOOD; CELL LINE; GENETICS; METABOLISM; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; URINE;

ACUTE KIDNEY INJURY; ANIMALS; BLOOD UREA NITROGEN; CELL LINE; CREATININE; GLUCURONIDASE; HEME OXYGENASE-1; HEPTANOIC ACIDS; IMIDAZOLES; LEUCYL AMINOPEPTIDASE; MALE; MALONDIALDEHYDE; OXAZOLES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXIDASE; PHOSPHORYLATION; PPAR ALPHA; PROMOTER REGIONS, GENETIC; PROTOPORPHYRINS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LIPOXIN; REPERFUSION INJURY; RNA, MESSENGER; TYROSINE;

EID: 84947922242     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0286-y     Document Type: Article

References (42)

1. Wen, X., R. Murugan, Z. Peng, and J.A. Kellum. 2010. Pathophysiology of acute kidney injury: a new perspective. Contributions to Nephrology 165: 39–45.
2. Eltzschig, H.K., and T. Eckle. 2011. Ischemia and reperfusion-from mechanism to translation. Nature Medicine 17: 1391–1401.
3. Chok, M.K., S. Ferlicot, M. Conti, A. Almolki, A. Dürrbach, S. Loric, et al. 2009. Renoprotective potency of heme oxygenase-1 induction in rat renal ischemia-reperfusion. Inflammation & Allergy Drug Targets 8: 252–259.
4. Nath, K.A. 2006. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney International 70: 432–443.
5. Li Volti, G., V. Sorrenti, P. Murabito, F. Galvano, M. Veroux, A. Gullo, et al. 2007. Pharmacological induction of heme oxygenase-1 inhibits iNOS and oxidative stress in renal ischemia-reperfusion injury. Transplantation Proceedings 39: 2986–2991.
6. Patel, N.S.A., R. di Paola, E. Mazzon, D. Britti, C. Thiemermann, and S. Cuzzocrea. 2008. Peroxisome proliferator-activated receptor-α contributes to the resolution of inflammation after renal ischemia/reperfusion injury. Journal of Pharmacology and Experimental Therapeutics 328: 635–643.
7. Miglio, G., A.C. Rosa, L. Rattazzi, C. Grange, M. Collino, G. Camussi, et al. 2011. The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury. British Journal of Pharmacology 162: 111–125.
8. Cheng, C.F., W.S. Lian, S.H. Chen, P.F. Lai, H.F. Li, Y.F. Lan, et al. 2012. Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPARα-heme oxygenase-1 signaling pathway. Journal of Cellular Physiology 227: 239–249.
9. Li, S., K.K. Nagothu, V. Desai, T. Lee, W. Branham, C. Molan, et al. 2009. Transgenic expression of peroxisome proliferator-activated receptor-α in mice confers protection during acute kidney injury. Kidney International 76: 1049–1062.
10. Chen, H.H., T.W. Chen, and H. Lin. 2009. Prostacycin-induced peroxisome proliferator-activated receptor-α translocation attenuates NF-κB and TNF-α activation after renal ischemia-reperfusion injury. American Journal of Physiology. Renal Physiology 297: F1109–F1118.
11. Chen, H.H., T.W. Chen, and H. Lin. 2010. Pravastatin attenuates carboplatin-induced nephrotoxicity in rodents via peroxisome proliferator-activated receptor α-regulated heme oxygenase-1. Molecular Pharmacology 78: 36–45.
12. Serhan, C.N. 2014. Novel pro-resolving lipid mediators in inflammation are leads for resolution physiologyas. Nature 510: 92–101.
13. Serhan, C.N., and N. Chiang. 2008. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. British Journal of Pharmacology 153: S200–S215.
14. 4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism. Thrombosis and Haemostasis 97: 88–98.
15. 4-methyl ester, a synthetic analogue of 15-epi-lipoxin A4, is protective in experimental ischemic acute renal failure. Journal of the American Society of Nephrology 13: 1657–1662.
16. Kieran, N.E., P.P. Doran, S.B. Connolly, M.C. Greenan, D.F. Higgins, M. Leonard, et al. 2003. Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney International 64: 480–492.
17. 4 induces heme oxygenase-1 in endothelial cells. American Journal of Physiology. Cell Physiology 289: C557–C563.
18. 4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB Journal 21: 2257–2266.
19. 4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1. Anesthesia and Analgesia 104: 369–377.
20. 4-induced heme oxygenase-1 protects cardiomyocytes against hypoxia/reoxygenation injury via p38 MAPK activation and Nrf2/ARE complex. PLoS One 8, e67120.
21. 4-induced protective effects on hypoxia/reoxygenation injury of cardiomyocytes. Prostaglandins, Leukotrienes, and Essential Fatty Acids 88: 391–397.
22. 4 by 5-lipoxygenase mediates PPARγ-dependent, neuroprotective effects of rosiglitazone in experimental stroke. Journal of Neuroscience 29: 3875–3884.
23. 4. Pediatric Research 64: 393–398.
24. 4 in human renal mesangial cells. Journal of Biological Chemistry 275: 27566–27575.
25. Lin, H., C.H. Yu, C.Y. Jen, C.F. Cheng, Y. Chou, C.C. Chang, et al. 2010. Adiponection-mediated heme oxygenase-1 induction protects against iron-induced liver injury via a PPARα-dependent mechanism. American Journal of Pathology 177: 1697–1709.
26. 4 inhibits transition of epithelial to mesenchymal cells in proximal tubules. American Journal of Nephrology 32: 122–136.
27. 4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells. Kidney International 69: 248–256.
28. 4 of production of interleukins in endothelial cells by lipopolysaccharide. Inflammation Research 57: 430–437.
29. 4 on mesangioproliferative nephritis in rats. Prostaglandins, Leukotrienes, and Essential Fatty Acids 76: 173–180.
30. Zhang, L., X. Zhang, P. Wu, H. Li, S. Jin, X. Zhou, et al. 2008. BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis. Inflammation Research 57: 157–162.
31. Kieran, N.E., P. Maderna, and C. Godson. 2004. Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. Kidney International 65: 1145–1154.
32. Ohse, T., T. Ota, N. Kieran, C. Godson, K. Yamada, T. Tanaka, et al. 2004. Modulation of interferon-induced genes by lipoxin analogue in anti-glomerular membrane nephritis. Journal of the American Society of Nephrology 15: 919–927.
33. 4 against rhabdomyolysis-induced acute kidney injury in rats. Chin J Cell Mol Immunol 28: 907–910 (in Chinese with English abstract).
34. Brennan, E.P., K.A. Nolan, E. Börgeson, O.S. Gough, C.M. McEvoy, N.G. Docherty, et al. 2013. Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1. Journal of the American Society of Nephrology 24: 627–637.
35. 4 attenuate experimental renal fibrosis. FASEB Journal 25: 2967–2979.
36. Börgeson, E., A.M.F. Johnson, Y.S. Lee, A. Till, G.H. Syed, S.T. Ali-Shah, et al. 2015. Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease. Cell Metabolism 22: 1–13.
37. Zhang, L., J. Wan, H. Li, P. Wu, S. Jin, X. Zhou, et al. 2007. Protective effects of BML-111, a lipoxin A4 receptor agonist, on carbon tetrachloride-induced liver injury in mice. Hepatology Research 37: 948–956.
38. Gong, J., S. Guo, H.B. Li, S.Y. Yuan, Y. Shang, and S.L. Yao. 2012. BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats. Resuscitation 83: 907–912.
39. Hawkins, K.E., K.M. DeMars, J. Singh, C. Yang, H.S. Cho, J.C. Frankowski, et al. 2014. Neurovascular protection by post-ischemic intravenous injections of the lipoxin A4 receptor agonist, BML-111, in a rat model of ischemic stroke. Journal of Neurochemistry 129: 130–142.
40. Wang, Y.Z., Y.C. Zhang, J.S. Cheng, Q. Ni, P.W. Li, W. Han, et al. 2014. Protective effects of BML-111 on cerulein-induced acute pancreatitis-associated lung injury via activation of Nrf2/ARE signaling pathway. Inflammation 37(4): 1120–1133.
41. Park, S.Y., J.U. Bae, K.W. Hong, and C.D. Kim. 2011. HO-1 induced by cilostazol protects against TNF-α-associated cytotoxicity via a PPAR-γ-dependent pathway in human endothelial cells. Korean J Physiol Pharmacol 15: 83–66.
42. Krönke, G., A. Kadl, E. Ikonomu, S. Blüml, A. Fürnkranz, I.J. Sarembock, et al. 2007. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 1276–1282.